The subgroups involved stratification by sex, alpha-fetoprotein (AFP; ≤400, >400), Eastern Cooperative Oncology Group (ECOG) performance status (PS), hepatitis B and C status, locoregional therapy, extrahepatic spread status, and portal vein thrombosis status. The gene discussed is AFP; the disease is Portal vein thrombosis.